CTOs on the Move

Trice Medical

www.tricemedical.com

 
Trice Medical was founded to fundamentally improve orthopedic diagnostics. Trice has pioneered fully integrated camera-enabled technologies that provide a clinical solution that is optimized for the physicians office. Our mission is to provide more immediate and definitive patient care, eliminating the false reads associated with current indirect modalities and significantly reduce the overall cost to the healthcare system.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Trice Medical raised $19.3M on 06/06/2017
Trice Medical raised $18.3M on 01/14/2019

Similar Companies

Surge Medical

Surge Medical Inc. is a Holland, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lab Vision Corporation

Lab Vision Corporation is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Armetheon

Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ability to offer peace of mind to patients while benefitting physicians, who may wish to reduce safety concerns, side effects and adverse events for their patients.  

Luminex Corporation

Luminex Corporation is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardiac Dimensions

Cardiac Dimensions® is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation.